-
-
-
-
-
-
-
Delcath Systems (DCTH) Tops Q4 EPS by 3c
-
-
-
-
-
-
-
Delcath Systems reports CHOPIN trial meets primary endpoint
-
-
-
-
-
-
-
Delcath Systems (DCTH) Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
-
-
-
-
-
-
-
Delcath Systems (DCTH) Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
Delcath Systems (DCTH) Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients
-
-
-
-
408,193 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

